FDA Inspection 725013 — Raritan Pharmaceuticals, Inc.
The FDA completed an inspection of Raritan Pharmaceuticals, Inc. on May 18, 2011 in East Brunswick, NJ. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 18, 2011
- Fiscal Year
- 2011
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- East Brunswick, NJ (United States)